Glenmede Trust CO Na Viatris Inc Transaction History
Glenmede Trust CO Na
- $19.1 Billion
- Q4 2024
A detailed history of Glenmede Trust CO Na transactions in Viatris Inc stock. As of the latest transaction made, Glenmede Trust CO Na holds 20,089 shares of VTRS stock, worth $153,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,089
Previous 22,349
10.11%
Holding current value
$153,279
Previous $259,000
3.47%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VTRS
# of Institutions
1,143Shares Held
989MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.08 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$707 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$486 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$477 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$448 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $9.25B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...